FDA Approves Emergent BioSolutions ' Anthrax Vaccine FDA Approves Emergent BioSolutions ' Anthrax Vaccine
Emergent BioSolutions said on Thursday the US Food and Drug Administration has approved its anthrax vaccine for use in adults aged 18 through 65.Reuters Health Information
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news
More News: Anthrax | Anthrax Vaccine | Food and Drug Administration (FDA) | Infectious Diseases | Vaccines